To address whether VPF potency in NB is strictly dependent on YAP, we tested VPF cytotoxicity in CRISPR/Cas9-mediated YAP/TAZ knock-out lines, as well as the predominantly YAP/TAZ-negative BE(2)-M17 NB cell line. This evidence concerns the gene YAP1 and neuroblastoma.